Accuracy of trisomy 18 screening using the second-trimester triple test

Prenatal Diagnosis

Volumn 23, Issue 6, 2003, Pages 443-446

  Meier, Chris ^a   Huang, Tianhua ^a   Wyatt, Philip R ^a   Summers, Anne M ^a  

^a NORTH YORK GENERAL HOSPITAL   (Canada)

Author keywords

Down syndrome; Maternal serum screening; Prevalence; Risk; Trisomy 18 syndrome

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; TRISOMY 18;

ADULT; BIOLOGICAL MARKERS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GENETIC SCREENING; HUMANS; ONTARIO; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK; TRISOMY;

EID: 0038123018     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.614     Document Type: Article

References (10)

1. Canick JA, Palomaki GE, Osathanondh R. 1990. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 10: 546-548.
2. Canick JA, Rish S. 1998. The accuracy of assigned risk in maternal serum screening. Prenat Diagn 18: 413-415.
3. Cuckle HS, Wald NJ, Thompson SG. 1987. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94: 387-402.
4. Hook EB, Cross PK, Schreinemachers DM. 1983. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 249: 2034-2038.
5. Hook EB, Hamerton JL. 1977. The frequency of chromosome abnormalities detected in consecutive newborn studies-differences between studies-results by sex and by severity of phenotypic involvement. In Population Cytogenetics: Studies in Humans, Hook EB, Porter IH (eds). Academic Press: New York; 63-79.
6. Lindenbaum RH, Ryynanen M, Holmes-Siedle M, Puhakainen E, Jonasson J, Keenan J. 1987. Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein. Prenat Diagn 7: 511-519.
7. Meier C, Huang T, Wyatt PR, Summers AM. 2002. Accuracy of expected risk of Down syndrome using the second-trimester triple test. Clin Chem 48: 653-655.
8. Palomaki GE, Haddow JE, Knight GJ, et al. 1995. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 15: 713-723.
9. Wald NJ, Hackshaw AK, Huttly W, Kennard A. 1996. Empirical validation of risk screening for Down syndrome. J Med Screen 3: 185-187.
10. Wald NJ, Huttly W. 1999. Validation of risk estimation using the quadruple test in prenatal screening for Down syndrome. Prenat Diagn 19: 1083, 1084.